Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Smid, Marcela
STORC, NCT05140941: Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy	Recruiting	4	100	Canada, US	Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet, Epclusa	Catherine Anne Chappell, Gilead Sciences	Hepatitis C, Chronic, Pregnancy; Infection	06/25	12/25
NCT05128071: PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT)	Recruiting	1	40	US	Progesterone, Placebo	University of Utah	Methamphetamine-dependence, Postpartum Abstinence	04/26	04/27
SERENE, NCT06452355: Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage	Recruiting	N/A	52	US	KOKO Device	KOKO Medical Inc.	Postpartum Hemorrhage, Immediate Postpartum Hemorrhage, Hemorrhage, Postpartum	06/25	07/25
Eastabrook, Genevieve
STORC, NCT05140941: Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy	Recruiting	4	100	Canada, US	Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet, Epclusa	Catherine Anne Chappell, Gilead Sciences	Hepatitis C, Chronic, Pregnancy; Infection	06/25	12/25
IMPACT, NCT05899101: The Impact of Opioid and Cannabis Exposure on Fetal Growth	Recruiting	N/A	546	Canada		Dr. Laura Gaudet, University of Ottawa	Pregnancy Related, Substance Use, Fetal Growth Retardation, Placenta Diseases	09/26	12/26